查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲質譜和層析法診斷市場（按產品類型、泰國應用和國家分類）分析和預測（2024-2033 年）
市場調查報告書
商品編碼
1650831

歐洲質譜和層析法診斷市場（按產品類型、泰國應用和國家分類）分析和預測（2024-2033 年）

Europe Mass Spectrometry and Chromatography in Diagnostics Market: Focus on Product Type, Application Type, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 76 Pages | 商品交期: 1-5個工作天內

價格

預計 2024 年歐洲診斷質譜和層析法分析市場價值將達到 2.24 億美元。

預計 2024 年至 2033 年期間市場複合年成長率為 9.41%，2033 年達到 5.033 億美元。歐洲分析和生命科學儀器產業嚴重依賴質譜（MS）和層析法市場。這些技術為化學和生物物質的分離、鑑定和定量提供了先進的技術，推動了醫學、環境監測、診斷和食品安全等領域的進步。質譜法和層析法不單獨使用，但通常整合到診斷工作流程中。例如，液相層析法質譜儀結合了質譜儀的質量分析能力和液相層析法的分離能力，使其成為複雜樣品分析的理想選擇。這種混合方法在臨床環境中特別有益，因為患者樣本的高通量分析對於提供指南診斷和治療的深入見解至關重要。這些技術在歐洲的重要診斷應用包括維生素分析、荷爾蒙分析和其他需要精確分離和分析成分的測試。

主要市場統計數據
預測期 2024-2033
2024 年評估 2.24億美元
2033 年預測 5.033億美元
複合年成長率 9.41％

患者樣本日益複雜以及對精準診斷的需求正在推動歐洲診斷質譜和層析法市場的快速發展。臨床診斷、個人化醫療和生物標記的發現都依賴質譜 (MS) 和層析法技術。質譜（MS）和層析法技術為化學和生物物質的分離、鑑定和定量提供了先進的技術。

液相層析法質譜 (LC-MS) 等混合系統已成為現代診斷工作流程中不可或缺的一部分，因為它們能夠對複雜的臨床樣本進行高通量、準確和可靠的分析。這些技術對於維生素、代謝物、荷爾蒙和生物標記的分析特別有用，可以早期發現疾病並制定個人化的治療方案。

代謝體學和蛋白​​質組學的治療改進也推動了市場的發展，因為它們有助於更好地進行疾病監測、篩檢和治療計劃。生物標記識別和標靶治療研究的不斷增多，進一步刺激了對高性能診斷工具的需求。

此外，在監管支援、醫療保健基礎設施加強和主導分析的推動下，質譜和層析法在診斷領域的應用正在整個歐洲不斷擴大。隨著這些技術變得越來越普及，預計它們將廣泛應用於一系列臨床應用，並支持歐洲診斷市場的持續擴張。

本報告研究了歐洲診斷市場的質譜和層析法，並概述了市場狀況以及產品類型、應用區域、國家和參與市場的公司概況等趨勢。

目錄

執行摘要

第 1層析法。

  • 市場概況
  • 主要趨勢
  • 主要趨勢的機會評估
  • 產品基準
  • 監管狀態

第2章 區域

  • 區域概況
  • 促進因素與限制因素
  • 歐洲

3. 歐洲診斷質譜和層析法分析市場：競爭基準化分析和公司概況

  • 競爭格局
    • 夥伴關係、合作和業務擴展
    • 新服務
    • 合併和收購
    • 監管部門核准
  • 關鍵策略和發展
  • 企業競賽矩陣
  • 企業市場占有率分析
  • 公司簡介
    • Tecan Group Ltd.
    • Merck KGaA
    • Chromsystems Instruments & Chemicals GmbH.
    • RECIPE Chemicals + Instruments GmbH
    • SENTINEL CH. SpA

第4章調查方法

Product Code: BHL2515SS

Introduction to Europe Mass Spectrometry and Chromatography in Diagnostics Market

The Europe mass spectrometry and chromatography in diagnostics market was valued at $224.0 million in 2024 and is expected to reach $503.3 million by 2033, growing at a CAGR of 9.41% between 2024 and 2033. The analytical and life sciences instrumentation sector in Europe relies heavily on the mass spectrometry (MS) and chromatography markets. These technologies propel advancements in pharmaceuticals, environmental monitoring, diagnostics, and food safety, among other fields, by offering sophisticated techniques for the separation, identification, and quantification of chemical and biological substances. Instead of being used separately, mass spectrometry and chromatography are usually incorporated into workflows in diagnostics. For instance, liquid chromatography-mass spectrometry is perfect for complex sample analysis because it combines the mass analysis capability of mass spectrometry with the separation power of liquid chromatography. In clinical settings, where high-throughput analysis of patient samples is crucial for offering thorough insights that guide diagnosis and treatment, this hybrid approach is especially beneficial. Important diagnostic uses for these technologies in Europe include vitamin profiling, hormone profiling, and other tests that require precise separation and analysis of components.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$224.0 Million
2033 Forecast$503.3 Million
CAGR9.41%

The growing complexity of patient samples and the growing need for precision diagnostics are driving the rapid evolution of the Europe mass spectrometry and chromatography in diagnostics market. Clinical diagnostics, personalized medicine, and the search for biomarkers all depend on mass spectrometry (MS) and chromatography technologies because they offer advanced techniques for the separation, identification, and quantification of chemical and biological materials.

Because they provide high-throughput, precise, and dependable analysis for complicated clinical samples, hybrid systems like liquid chromatography-mass spectrometry (LC-MS) have become essential to contemporary diagnostic workflows. These technologies are especially useful for analyzing vitamins, metabolites, hormones, and biomarkers, which allows for early disease detection and individualized treatment plans.

Improvements in metabolomics and proteomics are also driving the market since they are facilitating better disease monitoring, screening, and treatment planning. The need for high-performance diagnostic tools is being further stimulated by growing research into biomarker identification and targeted therapies.

Furthermore, the use of mass spectrometry and chromatography in diagnostics is expanding throughout Europe due to regulatory support, enhanced healthcare infrastructure, and the incorporation of AI-driven analytics. The use of these technologies is anticipated to spread across a variety of clinical applications as they become more widely available, propelling the European diagnostics market's ongoing expansion.

Market Segmentation:

Segmentation 1: by Product Type

  • Sample Preparation
  • Mass Spectrometry and Chromatography

Segmentation 2: by Application Type

  • Therapeutic Drug Monitoring
  • Vitamins
  • Hormones
  • Methylmalonic Acid
  • Immunosuppressants
  • Others

Segmentation 3: by Country

  • Germany
  • U.K.
  • Spain
  • Italy
  • France
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe mass spectrometry and chromatography market consists of various public and few private companies. Key players in the Europe mass spectrometry and chromatography in diagnostics market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Tecan Group Ltd.
  • Merck KGaA
  • Chromsystems Instruments & Chemicals GmbH
  • RECIPE Chemicals + Instruments GmbH
  • SENTINEL CH. SpA

Table of Contents

Executive Summary

Scope and Definition

1 Mass Spectrometry and Chromatography in Diagnostics Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Key Trends
    • 1.2.1 Shift toward Utilization of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as Standard Technique in Diagnostics
    • 1.2.2 Utilization of Automated Sample Preparation Technologies
  • 1.3 Opportunity Assessment of Key Trends
  • 1.4 Product Benchmarking
  • 1.5 Regulatory Landscape
    • 1.5.1 Regulatory Framework in Europe
      • 1.5.1.1 Recommendations for Diagnostic Approval

2 Region

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 By Product Type
    • 2.3.5 By Application Type
    • 2.3.6 U.K.
      • 2.3.6.1 By Product Type
      • 2.3.6.2 By Application Type
    • 2.3.7 Germany
      • 2.3.7.1 By Product Type
      • 2.3.7.2 By Application Type
    • 2.3.8 France
      • 2.3.8.1 By Product Type
      • 2.3.8.2 By Application Type
    • 2.3.9 Italy
      • 2.3.9.1 By Product Type
      • 2.3.9.2 By Application Type
    • 2.3.10 Spain
      • 2.3.10.1 By Product Type
      • 2.3.10.2 By Application Type
    • 2.3.11 Rest-of-Europe
      • 2.3.11.1 By Product Type
      • 2.3.11.2 By Application Type

3 Mass Spectrometry and Chromatography in Diagnostics Market: Competitive Benchmarking and Company Profile

  • 3.1 Competitive Landscape
    • 3.1.1 Partnerships, Alliances, and Business Expansions
    • 3.1.2 New Offerings
    • 3.1.3 Mergers and Acquisitions
    • 3.1.4 Regulatory Approvals
  • 3.2 Key Strategies and Development
  • 3.3 Company Competition Matrix
  • 3.4 Company Share Analysis
  • 3.5 Company Profiles
    • 3.5.1 Tecan Group Ltd.
      • 3.5.1.1 Overview
      • 3.5.1.2 Top Products
      • 3.5.1.3 Top Competitors
      • 3.5.1.4 Top Customers
      • 3.5.1.5 Key Personnel
      • 3.5.1.6 Analyst View
    • 3.5.2 Merck KGaA
      • 3.5.2.1 Overview
      • 3.5.2.2 Top Products
      • 3.5.2.3 Top Competitors
      • 3.5.2.4 Top Customers
      • 3.5.2.5 Key Personnel
      • 3.5.2.6 Analyst View
    • 3.5.3 Chromsystems Instruments & Chemicals GmbH.
      • 3.5.3.1 Overview
      • 3.5.3.2 Top Products
      • 3.5.3.3 Top Competitors
      • 3.5.3.4 Top Customers
      • 3.5.3.5 Key Personnel
      • 3.5.3.6 Analyst View
    • 3.5.4 RECIPE Chemicals + Instruments GmbH
      • 3.5.4.1 Overview
      • 3.5.4.2 Top Products
      • 3.5.4.3 Top Competitors
      • 3.5.4.4 Top Customers
      • 3.5.4.5 Key Personnel
      • 3.5.4.6 Analyst View
    • 3.5.5 SENTINEL CH. SpA
      • 3.5.5.1 Overview
      • 3.5.5.2 Top Products
      • 3.5.5.3 Top Competitors
      • 3.5.5.4 Top Customers
      • 3.5.5.5 Key Personnel
      • 3.5.5.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation

List of Figures

  • Figure 1: Europe Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2024, 2028, and 2033
  • Figure 2: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 4: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 5: Product Benchmarking (Mass Spectrometry and Chromatography (by Instruments))
  • Figure 6: EU IVD Regulation
  • Figure 7: U.K. Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 8: Germany Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 9: France Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 10: Italy Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 11: Spain Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 12: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 13: Partnerships, Alliances, and Business Expansions, January 2015- June 2024
  • Figure 14: New Offerings, January 2015- June 2024
  • Figure 15: Mergers and Acquisitions, January 2015- June 2024
  • Figure 16: New Offerings, January 2015- June 2024
  • Figure 17: Mass Spectrometry and Chromatography in Diagnostics Market, Company Competition Matrix
  • Figure 18: Mass Spectrometry and Chromatography in Diagnostics Market, % Share, 2023
  • Figure 19: Data Triangulation
  • Figure 20: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Current State and Future Potential of Key Trends in the Europe Mass Spectrometry and Chromatography in Diagnostics Market
  • Table 3: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023-2033
  • Table 4: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 5: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 6: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 7: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 8: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 9: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 10: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 11: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 12: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 13: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 14: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 15: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 16: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 17: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 18: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 19: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 20: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 21: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 22: France Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 23: France Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 24: France Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 25: France Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 26: France Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 27: France Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 28: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 29: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 30: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 31: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 32: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 33: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 34: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 35: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 36: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 37: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 38: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 39: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 40: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 41: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 42: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 43: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 44: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 45: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 46: Mass Spectrometry and Chromatography in Diagnostics Market, Key Development Analysis, January 2015-June 2024